# Patient Connect

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/patient-connect

- Industry: Software
- Headquarters: Guildford, UK
- Website: www.patientconnect.co.uk
- Total disclosed funding: $1.9M
- Latest round: Series A (Nov 11, 2011)
- Investors on record: 1

## About

Patient Connect Limited specializes in enhancing patient engagement through AI-powered solutions for healthcare providers, aiming to improve decision-making and clinical outcomes in the life sciences sector.Founded in 2004 and headquartered in Guildford, UK, Patient Connect Limited focuses on integrating digital messaging solutions into healthcare systems. The company was acquired by Clarivate Analytics in December 2021, which has enabled a strategic pivot towards improving patient engagement and supporting healthcare professionals. The CEO, Navi Muradali, currently leads the firm, ensuring a focus on innovative solutions.Patient Connect Limited offers AI-driven platforms designed to enhance patient engagement and decision-making in life sciences. Their flagship product, Point of Care Digital Messaging, integrates with electronic health records to improve communication and inform both providers and patients at critical points of care, targeting areas such as medication adherence and behavioral change. The company serves a diverse client base including pharmaceutical firms and healthcare providers across North America, Europe, and Asia.In the most recent year, 2023, Patient Connect Limited reported a revenue of GBP 0 and an EBITDA of GBP 0, reflecting its focus on growth and reinvestment into its technological solutions.Following its acquisition in December 2021, Patient Connect Limited is focused on enhancing patient engagement and driving behavioral change within healthcare practices. The company plans to leverage its recent funding of GBP 1.15 mn from its Series A round to develop new products and expand into additional markets, with a particular focus on North America and Europe by 2024. This strategic approach aims to empower healthcare professionals and improve treatment accessibility for patients.

## Funding rounds

- Series A, Nov 11, 2011, $1.9M — MVM Partners

## Investors

- MVM Partners (https://capitalatlas.ai/funds/mvm-partners) — Series A
